KR102612094B1 - Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity - Google Patents
Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity Download PDFInfo
- Publication number
- KR102612094B1 KR102612094B1 KR1020210087871A KR20210087871A KR102612094B1 KR 102612094 B1 KR102612094 B1 KR 102612094B1 KR 1020210087871 A KR1020210087871 A KR 1020210087871A KR 20210087871 A KR20210087871 A KR 20210087871A KR 102612094 B1 KR102612094 B1 KR 102612094B1
- Authority
- KR
- South Korea
- Prior art keywords
- culture
- present
- strain
- xylan
- cryptocline
- Prior art date
Links
- 229920001221 xylan Polymers 0.000 title claims abstract description 44
- 150000004823 xylans Chemical class 0.000 title claims abstract description 41
- 230000000694 effects Effects 0.000 title abstract description 38
- 230000000593 degrading effect Effects 0.000 title description 2
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 37
- 239000005017 polysaccharide Substances 0.000 claims abstract description 37
- 150000004804 polysaccharides Chemical class 0.000 claims abstract description 37
- 150000002016 disaccharides Chemical class 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000012264 purified product Substances 0.000 claims description 20
- 229920000856 Amylose Polymers 0.000 claims description 10
- 229920000617 arabinoxylan Polymers 0.000 claims description 10
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 claims description 8
- 238000000354 decomposition reaction Methods 0.000 abstract description 26
- 238000010170 biological method Methods 0.000 abstract description 2
- -1 xylan Chemical class 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 description 27
- 108090000790 Enzymes Proteins 0.000 description 27
- 229940088598 enzyme Drugs 0.000 description 27
- 239000002609 medium Substances 0.000 description 19
- 239000001965 potato dextrose agar Substances 0.000 description 13
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 11
- 238000000746 purification Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 241000233866 Fungi Species 0.000 description 8
- 239000008186 active pharmaceutical agent Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 238000006911 enzymatic reaction Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 102000005936 beta-Galactosidase Human genes 0.000 description 5
- 108010005774 beta-Galactosidase Proteins 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 108090001060 Lipase Proteins 0.000 description 4
- 108010046334 Urease Proteins 0.000 description 4
- 239000000539 dimer Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 3
- 241000945760 Pseudosydowia eucalypti Species 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002414 glycolytic effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 229960002160 maltose Drugs 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 2
- WDMUXYQIMRDWRC-UHFFFAOYSA-N 2-hydroxy-3,4-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1O WDMUXYQIMRDWRC-UHFFFAOYSA-N 0.000 description 2
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108010082340 Arginine deiminase Proteins 0.000 description 2
- 241000223678 Aureobasidium pullulans Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 2
- 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 2
- 102000030900 Cystinyl aminopeptidase Human genes 0.000 description 2
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 229920002488 Hemicellulose Polymers 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 239000006035 Tryptophane Substances 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- FTTUBRHJNAGMKL-UHFFFAOYSA-N Xylohexaose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(OC5C(C(O)C(O)OC5)O)OC4)O)OC3)O)OC2)O)OC1 FTTUBRHJNAGMKL-UHFFFAOYSA-N 0.000 description 2
- JVZHSOSUTPAVII-UHFFFAOYSA-N Xylotetraose Natural products OCC(OC1OCC(OC2OCC(OC3OCC(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)C(O)C=O JVZHSOSUTPAVII-UHFFFAOYSA-N 0.000 description 2
- 102000005840 alpha-Galactosidase Human genes 0.000 description 2
- 108010030291 alpha-Galactosidase Proteins 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 2
- 229940089837 amygdalin Drugs 0.000 description 2
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 229940093496 esculin Drugs 0.000 description 2
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 2
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-ABXHMFFYSA-N melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-ABXHMFFYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000004224 potassium gluconate Substances 0.000 description 2
- 229960003189 potassium gluconate Drugs 0.000 description 2
- 235000013926 potassium gluconate Nutrition 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- KPTPSLHFVHXOBZ-BIKCPUHGSA-N xylotetraose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H]([C@@H](O)C(O)OC3)O)OC2)O)OC1 KPTPSLHFVHXOBZ-BIKCPUHGSA-N 0.000 description 2
- SWMBOMMGMHMOHE-KZXKDKCNSA-N (2r,3r,4r,5r)-hexane-1,2,3,4,5,6-hexol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SWMBOMMGMHMOHE-KZXKDKCNSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 1
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710180684 Beta-hexosaminidase Proteins 0.000 description 1
- 101710124976 Beta-hexosaminidase A Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000222059 Kabatiella microsticta Species 0.000 description 1
- 108010048581 Lysine decarboxylase Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 241000346865 Pringsheimia Species 0.000 description 1
- 241000346852 Pringsheimia smilacis Species 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 101710081801 Protein O-GlcNAcase Proteins 0.000 description 1
- 101710199095 Putative beta-hexosaminidase Proteins 0.000 description 1
- 241000743422 Saccothecium rubi Species 0.000 description 1
- 241001406051 Saccothecium sepincola Species 0.000 description 1
- 241000907561 Sydowia polyspora Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- ROWKJAVDOGWPAT-UHFFFAOYSA-N acetyl methyl carbinol Natural products CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- PYMYPHUHKUWMLA-VAYJURFESA-N aldehydo-L-arabinose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VAYJURFESA-N 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 102000019199 alpha-Mannosidase Human genes 0.000 description 1
- 108010012864 alpha-Mannosidase Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000002856 computational phylogenetic analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000002367 glucuronosyl group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 자일란 분해 활성을 갖는 신규 균주 크립토클라인 아르크토스타필리(Cryptocline arctostaphyli) RN2 및 이를 이용한 다당류 분해 방법, 다당류 분해용 조성물, 이당류 제조 방법 및 이당류 제조용 조성물에 관한 것이다.
본 발명에 따르면 자일란을 포함한 다양한 다당류를 생물학적인 방법을 통해 매우 효과적으로 분해할 수 있으며, 특히 자일란으로부터 이당류를 효과적으로 제조할 수 있다.The present invention relates to a new strain Cryptocline arctostaphyli RN2 with xylan decomposition activity, a method for decomposing polysaccharides using the same, a composition for decomposing polysaccharides, a method for producing disaccharides, and a composition for producing disaccharides.
According to the present invention, various polysaccharides, including xylan, can be decomposed very effectively through biological methods, and in particular, disaccharides can be effectively produced from xylan.
Description
본 발명은 자일란 분해 활성을 갖는 신규 균주 크립토클라인 아르크토스타필리 RN2 및 이를 이용한 다당류 분해 방법, 다당류 분해용 조성물, 이당류 제조 방법 및 이당류 제조용 조성물에 관한 것이다.The present invention relates to a new strain Cryptocline Arctostaphylli RN2 having xylan decomposition activity and a method for decomposing polysaccharides using the same, a composition for decomposing polysaccharides, a method for producing disaccharides, and a composition for producing disaccharides.
자일란(xylan)은 육상 식물체 세포벽의 약 20 내지 40%를 차지하는 주요 구성성분의 하나인 헤미셀룰로오스(hemicellulose)로서 아라비노실기(arabinosyl), 아세틸기(acetyl), 글루쿠로노실기(glucuronosyl) 등으로 치환된 β-1,4-연결 자일로오스(β-1,4-linked xylose) 단위체로 구성된 복잡한 구조를 가지고 있으며, 다양한 자일라나아제(xylanase)에 의해서 가수분해될 수 있다.Xylan is hemicellulose, one of the main components that accounts for about 20 to 40% of the cell walls of land plants, and is composed of arabinosyl, acetyl, and glucuronosyl. It has a complex structure composed of substituted β-1,4-linked xylose units, and can be hydrolyzed by various xylanases.
자일라나아제는 펄프의 헤미셀룰로오스를 제거하기 위한 펄프-표백전 과정, 가축사료의 소화 촉진, 식품 및 제빵 첨가물, 과일 및 채소 가공 과정, 에탄올 및 자일리톨 생산, 제지 분야 등의 다양한 분야에서 요구되는데, 각 분야에 적합한 자일라나아제의 특성에 관한 연구가 요구되고 있다. 또한 자일라나아제에 의해 생산되는 자일란 가수분해산물인 자일로올리고당(XOS)은 항균, 항산화, 항염증 등 다양한 생리활성을 갖는 것으로 알려져 있어 식-의약 산업, 농-축산업, 화장품 산업 등 다양한 분야에 이용될 수 있을 것으로 기대된다.Xylanase is required in various fields such as the pulp-pre-bleaching process to remove hemicellulose from the pulp, promoting digestion of livestock feed, food and baking additives, fruit and vegetable processing, ethanol and xylitol production, and papermaking. Research on the characteristics of xylanase suitable for the field is required. In addition, xylooligosaccharide (XOS), a xylan hydrolysis product produced by xylanase, is known to have various physiological activities such as antibacterial, antioxidant, and anti-inflammatory, and is used in various fields such as food-pharmaceutical industry, agricultural-livestock industry, and cosmetics industry. It is expected that it can be used.
앞에서 언급한 자일라나아제와 같은 가수분해 효소를 이용한 분해법은 선택적이고 특이적으로 다당류를 가수분해하여 목적으로 하는 올리고당을 생산할 수 있다는 장점이 있다. 특히, 미생물 효소에 의한 식물 바이오매스의 가수분해법은 유해 부산물을 생성하는 화학적 분해법에 대한 대안으로서 환경 친화적인 방법으로 받아들여진다. 이러한 이유로 많은 연구자들이 좀 더 적합한 효소를 생산하는 신규 미생물의 분리를 시도하고 있다.The decomposition method using a hydrolytic enzyme such as xylanase mentioned above has the advantage of being able to selectively and specifically hydrolyze polysaccharides to produce the target oligosaccharide. In particular, hydrolysis of plant biomass using microbial enzymes is accepted as an environmentally friendly alternative to chemical decomposition methods that produce harmful by-products. For this reason, many researchers are attempting to isolate new microorganisms that produce more suitable enzymes.
이에 본 발명자들은 자일란의 생물학적 분해(효소적 분해) 및 자일란으로부터 특정한 분해산물을 생산하는데 이용할 수 있는 새로운 미생물을 발굴하고자 하였다.Accordingly, the present inventors sought to discover new microorganisms that could be used to biologically decompose (enzymatically) decompose xylan and produce specific decomposition products from xylan.
따라서 본 발명의 주된 목적은 자일란의 생물학적 분해 및 자일란으로부터 특정한 분해산물을 생산하는데 이용할 수 있는 새로운 미생물을 제공하는데 있다.Therefore, the main purpose of the present invention is to provide a new microorganism that can be used to biologically decompose xylan and produce specific decomposition products from xylan.
본 발명의 다른 목적은 상기 미생물을 활용하는 방법을 제공하는데 있다.Another object of the present invention is to provide a method of utilizing the microorganism.
본 발명의 또 다른 목적은 상기 미생물을 활용한 물건을 제공하는데 있다.Another object of the present invention is to provide a product utilizing the above microorganisms.
본 발명의 한 양태에 따르면, 본 발명은 수탁번호 KACC 93360P로 기탁된 크립토클라인 아르크토스타필리(Cryptocline arctostaphyli) RN2 균주를 제공한다.According to one aspect of the present invention, the present invention provides Cryptocline arctostaphyli RN2 strain deposited under accession number KACC 93360P.
본 발명의 다른 양태에 따르면, 본 발명은 상기 균주의 배양물 또는 상기 배양물의 정제물을 다당류와 접촉시키는 단계를 포함하는 다당류 분해 방법을 제공한다.According to another aspect of the present invention, the present invention provides a method for decomposing polysaccharides comprising contacting a culture of the strain or a purified product of the culture with a polysaccharide.
본 발명의 다당류 분해 방법에 있어서, 상기 다당류는 자일란, 아라비노자일란 또는 아밀로오스인 것이 바람직하다.In the polysaccharide decomposition method of the present invention, the polysaccharide is preferably xylan, arabinoxylan, or amylose.
본 발명의 또 다른 양태에 따르면, 본 발명은 상기 균주의 배양물 또는 상기 배양물의 정제물을 포함하는 다당류 분해용 조성물을 제공한다.According to another aspect of the present invention, the present invention provides a composition for decomposing polysaccharides comprising a culture of the above strain or a purified product of the above culture.
본 발명의 다당류 분해용 조성물에 있어서, 상기 다당류는 자일란, 아라비노자일란 또는 아밀로오스인 것이 바람직하다.In the composition for decomposing polysaccharides of the present invention, the polysaccharide is preferably xylan, arabinoxylan, or amylose.
본 발명의 또 다른 양태에 따르면, 본 발명은 상기 균주의 배양물 또는 상기 배양물의 정제물을 자일란과 접촉시키는 단계를 포함하는 이당류 제조 방법을 제공한다.According to another aspect of the present invention, the present invention provides a method for producing a disaccharide comprising contacting a culture of the strain or a purified product of the culture with xylan.
본 발명의 또 다른 양태에 따르면, 본 발명은 상기 균주의 배양물 또는 상기 배양물의 정제물을 포함하는 이당류 제조용 조성물을 제공한다.According to another aspect of the present invention, the present invention provides a composition for producing a disaccharide comprising a culture of the above strain or a purified product of the above culture.
본 발명에 따르면 자일란을 포함한 다양한 다당류를 생물학적인 방법을 통해 매우 효과적으로 분해할 수 있으며, 특히 자일란으로부터 이당류를 효과적으로 제조할 수 있다.According to the present invention, various polysaccharides, including xylan, can be decomposed very effectively through biological methods, and in particular, disaccharides can be effectively produced from xylan.
도 1은 본 발명 균주의 ITS-D1D2 서열을 토대로 분석한 NJ(Neighbor-Joining) 계통수를 나타낸 것이다.
도 2는 고체배지 상에서 성장한 본 발명 균주의 균체를 현미경을 통해 촬영한 사진(좌측)과 고체배지 상에 형성된 본 발명 균주의 콜로니를 촬영한 사진(우측)을 나타낸 것이다. 우측의 콜로니 촬영 사진에서 좌측('(위)'로 표시)은 배지의 상면(top)을 촬영한 것이고, 우측('(아래)'로 표시)은 배지의 바닥면(bottom)을 촬영한 것이다.
도 3은 본 발명 균주의 다당체 분해 활성 실험 결과를 나타낸 것이다. (A), 아밀로오스 분해 활성 실험결과; (B), 자일란 분해 활성 실험결과; (C), 아라비노자일란 분해 활성 실험결과.
도 4는 본 발명 균주의 배양 시간에 따른 자일라나아제 활성 실험결과를 나타낸 것이다.
도 5는 본 발명 균주의 조효소액과 자일란의 반응물을 TLC로 분석한 결과를 나타낸 것이다. G, 글루코오스; X2, 자일로바이오스(xylobiose); X4, 자일로테트라오스(xylotetraose); X6, 자일로헥사오스(xylohexaose); R, 반응물.
도 6은 본 발명 균주의 미생물 수탁증을 나타낸 것이다.Figure 1 shows the NJ (Neighbor-Joining) phylogenetic tree analyzed based on the ITS-D1D2 sequence of the strain of the present invention.
Figure 2 shows a photograph taken through a microscope of the bacterial cells of the strain of the present invention grown on a solid medium (left) and a photograph taken of colonies of the strain of the present invention formed on a solid medium (right). In the colony photo on the right, the left side (marked '(top)') is a shot of the top of the medium, and the right side (marked '(bottom)') is a shot of the bottom of the medium. .
Figure 3 shows the results of a polysaccharide decomposition activity test of the strain of the present invention. (A), amylose decomposition activity test results; (B), xylan decomposition activity test results; (C), Arabinoxylan decomposition activity test results.
Figure 4 shows the results of xylanase activity experiments according to culture time of the strain of the present invention.
Figure 5 shows the results of TLC analysis of the reaction product of the crude enzyme solution and xylan of the strain of the present invention. G, glucose; X2, xylobiose; X4, xylotetraose; X6, xylohexaose; R, reactant.
Figure 6 shows the microbial deposit of the strain of the present invention.
본 발명의 신규 균주 크립토클라인 아르크토스타필리(Cryptocline arctostaphyli) RN2는 장미꽃에서 단리되어 국립농업과학원 미생물은행(Korean Agricultural Culture Collection, KACC)에 수탁번호 KACC 93360P로 기탁되어 있다.The new strain Cryptocline arctostaphyli RN2 of the present invention was isolated from rose flowers and deposited in the Korean Agricultural Culture Collection (KACC) of the National Institute of Agricultural Sciences under the accession number KACC 93360P.
본 발명의 균주는 서열번호 1의 ITS 서열 및 서열번호 2의 D1D2 서열을 갖는다. ITS 서열 및 D1D2 서열은 균류를 식별하는데 이용되는 대표적인 서열로, 본 발명 균주의 ITS 서열 및 D1D2 서열은 기존에 알려진 크립토클라인 아르크토스타필리의 ITS 서열 및 D1D2 서열과 비교하여 차이가 있다.The strain of the present invention has the ITS sequence of SEQ ID NO: 1 and the D1D2 sequence of SEQ ID NO: 2. The ITS sequence and D1D2 sequence are representative sequences used to identify fungi, and the ITS sequence and D1D2 sequence of the strain of the present invention are different compared to the ITS sequence and D1D2 sequence of the previously known cryptocline Arctostaphylli.
본 발명의 균주는 다당류인 자일란, 아라비노자일란 및 아밀로오스를 분해할 수 있으며, 특히 자일란을 분해하여 이당류, 즉 단당류 분자 2개로 이루어진 이량체(dimer)(DP2)를 주요 산물로 생산할 수 있다.The strain of the present invention can decompose polysaccharides such as xylan, arabinoxylan, and amylose, and in particular, can decompose xylan to produce disaccharide, that is, a dimer (DP2) consisting of two monosaccharide molecules, as the main product.
크립토클라인 아르크토스타필리는 1984년 스위스에서 곰들쭉(Arctostaphylos uva-ursi)의 식물내생생물(endophyte)로 분리되어 그 존재가 알려졌으나, 최근까지 이 균주를 이용한 연구는 세계적으로 전무한 상태이다. 또한 우리나라에서도 균주 분리 및 연구 결과가 발표된 바 없는 국내 미기록종이다.The cryptocline Arctostaphylli was isolated as an endophyte of Arctostaphylos uva-ursi in Switzerland in 1984 and its existence was known, but until recently, there was no research using this strain worldwide. In addition, it is a domestically unrecorded species for which no strain isolation or research results have been published in Korea.
본 발명의 균주는 세포 외에서 상기와 같은 다당류의 분해 활성 및 자일란으로부터 이당류를 생산하는 활성을 나타낼 수 있다. 이는 균체 제거 배양액을 사용한 다당류(자일란 포함)의 분해 활성 실험 결과를 통해 확인된 것으로, 이러한 활성과 관련된 효소, 예를 들어 자일라나아제를 세포 외부로 분비할 수 있음을 시사한다.The strain of the present invention can exhibit the above-mentioned polysaccharide decomposition activity and the activity of producing disaccharide from xylan outside the cell. This was confirmed through the results of experiments on the decomposition activity of polysaccharides (including xylan) using bacterial removal culture media, suggesting that enzymes related to this activity, such as xylanase, can be secreted to the outside of the cell.
본 발명의 균주는 균류(fungus), 특히 크립토클라인(Cryptocline) 속의 균류, 특히 크립토클라인 아르크토스타필리(Cryptocline arctostaphyli) 종의 균류를 배양하는 통상의 배양 방법에 따라 배양할 수 있다. 예를 들어 배지로 고체배양의 경우 PDA(potato dextrose agar) 배지, 액체배양의 경우 PDB(potato dextrose broth) 배지를 사용하여, 20 내지 40℃의 온도 조건으로 배양할 수 있다.The strain of the present invention can be cultured according to a conventional culture method for culturing fungi, especially fungi of the Cryptocline genus, especially fungi of the Cryptocline arctostaphyli species. For example, for solid culture, PDA (potato dextrose agar) medium can be used, and for liquid culture, PDB (potato dextrose broth) medium can be used, and the culture can be done under temperature conditions of 20 to 40°C.
상기와 같은 본 발명 균주의 특징을 바탕으로 본 발명은 본 발명 균주의 배양물 또는 상기 배양물의 정제물을 다당류와 접촉시키는 단계를 포함하는 다당류 분해 방법을 제공한다.Based on the characteristics of the strain of the present invention as described above, the present invention provides a method of decomposing polysaccharides comprising the step of contacting a culture of the strain of the present invention or a purified product of the culture with a polysaccharide.
본 발명에서 본 발명 균주의 배양물은 위에서 설명한 배양 방법에 따라 본 발명 균주를 배양하여 수득할 수 있다. 바람직하게는 본 발명 균주의 배양물은 PDB 배지에서 배양하여 수득되는 것이다. 보다 바람직하게는 본 발명 균주의 배양물은 PDB 배지에서 28 내지 32℃로 2일 내지 4일 동안 배양하여 수득되는 것이고, 더욱 바람직하게는 29 내지 31℃로 60시간 내지 84시간 동안 배양하여 수득되는 것이다. 이에 따르면 보다 높은 다당류 분해 활성을 갖는 배양물을 수득할 수 있다. 본 발명 균주의 배양물은 바람직하게는 액체배지에서 배양한 배양물에서 균체를 제거한 것이다. 이는 배양물에서 균체를 제거하는 통상적인 방법, 예를 들어 원심분리, 여과 등의 방법을 사용하여 달성할 수 있다.In the present invention, a culture of the present strain can be obtained by culturing the present strain according to the culture method described above. Preferably, the culture of the strain of the present invention is obtained by culturing in PDB medium. More preferably, the culture of the strain of the present invention is obtained by culturing in PDB medium at 28 to 32 ℃ for 2 to 4 days, and more preferably, it is obtained by culturing at 29 to 31 ℃ for 60 to 84 hours. will be. According to this, a culture with higher polysaccharide decomposition activity can be obtained. The culture of the strain of the present invention is preferably obtained by removing the bacterial cells from a culture grown in a liquid medium. This can be achieved using conventional methods for removing bacterial cells from the culture, such as centrifugation and filtration.
본 발명에서 배양물의 정제물은 본 발명 균주의 배양물의 정제 과정을 통해 수득되는 것으로, 미생물, 특히 균류, 특히 크립토클라인 속의 균류, 특히 크립토클라인 아르크토스타필리 종의 균류의 배양물로부터 세포 외부로 분비되는 단백질, 특히 효소, 특히 당분해 효소를 정제하는데 사용되는 통상의 정제 과정을 통해 수득되는 것일 수 있다. 예를 들어, 균체를 제거한 배양액을 10KDa 컷-오프 필터로 필터링하여 수득되는 것일 수 있다.In the present invention, the purified product of the culture is obtained through the purification process of the culture of the strain of the present invention, and is obtained from a culture of microorganisms, especially fungi, especially fungi of the Cryptocline genus, especially fungi of the Cryptocline Arctostaphyll species, to the outside of the cell. It may be obtained through a conventional purification process used to purify secreted proteins, especially enzymes, especially glycolytic enzymes. For example, it may be obtained by filtering the culture medium from which the bacterial cells have been removed with a 10KDa cut-off filter.
본 발명의 다당류 분해 방법에서 다당류와 접촉시키는 단계는 바람직하게는 본 발명 균주의 배양물 또는 상기 배양물의 정제물을 자일란, 아라비노자일란 또는 아밀로오스와 접촉시키는 단계이며, 보다 바람직하게는 자일란과 접촉시키는 단계이다.In the polysaccharide decomposition method of the present invention, the step of contacting the polysaccharide is preferably a step of contacting the culture of the strain of the present invention or a purified product of the culture with xylan, arabinoxylan, or amylose, more preferably contacting the culture with xylan. It's a step.
본 발명 균주의 배양물 또는 상기 배양물의 정제물과 다당류의 접촉은 상기 배양물 또는 정제물에 다당류를 첨가하는 방법으로 수행될 수 있으며, 또한 완충액 중에서 이루어질 수 있다. 예를 들어, 완충액에 상기 배양물 또는 정제물과 다당류를 첨가하는 방법으로도 수행될 수 있다. 상기 접촉은 예를 들어 30 내지 40℃의 온도 조건에서 수행할 수 있으며, 바람직하게는 35 내지 39℃에서 수행한다.Contact between the culture of the strain of the present invention or a purified product of the culture and the polysaccharide can be carried out by adding polysaccharide to the culture or purified product, or can be done in a buffer solution. For example, it can also be performed by adding the culture or purification and polysaccharide to a buffer solution. The contact may be carried out, for example, at a temperature of 30 to 40°C, and is preferably carried out at 35 to 39°C.
상기와 같은 본 발명 균주의 특징을 바탕으로 본 발명은 또한 본 발명 균주의 배양물 또는 상기 배양물의 정제물을 포함하는 다당류 분해용 조성물을 제공한다.Based on the above characteristics of the strain of the present invention, the present invention also provides a composition for decomposing polysaccharides comprising a culture of the strain of the present invention or a purified product of the culture.
본 발명의 다당류 분해용 조성물에서 배양물 및 정제물에 관한 사항은 위에서 설명한 내용을 참조할 수 있다.Details regarding culture and purification in the composition for decomposing polysaccharides of the present invention can be referred to the information described above.
본 발명의 다당류 분해용 조성물은 상기 배양물 또는 정제물 이외에 다른 성분을 더 포함할 수 있다. 예를 들어, 상기 배양물 또는 정제물에 의한 다당류의 분해 활성을 실질적으로 저해하지 않는 성분으로, 당분해 효소의 안정적인 작용을 위한 완충제, 희석제, 부형제 등을 더 포함할 수 있다.The composition for decomposing polysaccharides of the present invention may further include other ingredients in addition to the culture or purification. For example, ingredients that do not substantially inhibit the decomposition activity of polysaccharides by the culture or purification may further include buffers, diluents, excipients, etc. for the stable action of glycolytic enzymes.
본 발명의 다당류 분해용 조성물은 상기 배양물 또는 정제물을 예를 들어 조성물 총 중량을 기준으로 0.001 내지 100%로 포함할 수 있다.The composition for decomposing polysaccharides of the present invention may include, for example, 0.001 to 100% of the culture or purified product based on the total weight of the composition.
상기와 같은 본 발명 균주의 특징을 바탕으로 본 발명은 또한 본 발명 균주의 배양물 또는 상기 배양물의 정제물을 자일란과 접촉시키는 단계를 포함하는 이당류 제조 방법을 제공한다. 이는 본 발명의 균주가 자일란을 분해하여 이당류를 주요 산물로 생산할 수 있고, 또한 이러한 활성이 균체를 제거한 배양액에서 발휘될 수 있다는 실험결과를 바탕으로 한다.Based on the above characteristics of the strain of the present invention, the present invention also provides a method for producing a disaccharide comprising the step of contacting a culture of the strain of the present invention or a purified product of the culture with xylan. This is based on experimental results showing that the strain of the present invention can decompose xylan and produce disaccharide as the main product, and that this activity can be exerted in a culture medium from which the bacteria have been removed.
본 발명의 이당류 제조 방법에서 배양물 및 정제물에 관한 사항은 위에서 설명한 내용을 참조할 수 있다.Details regarding culture and purification in the disaccharide production method of the present invention can be referred to the information described above.
본 발명 균주의 배양물 또는 상기 배양물의 정제물과 자일란의 접촉에 관한 사항은 상기 본 발명 균주의 배양물 또는 상기 배양물의 정제물과 다당류의 접촉에 관해 설명한 내용을 참조할 수 있다.For matters regarding contact between a culture of the strain of the present invention or a purified product of the culture and xylan, reference may be made to the description of contact between a culture of the strain of the present invention or a purified product of the culture and polysaccharide.
본 발명의 이당류 제조 방법은 상기 자일란과 접촉시키는 단계 이후 생성된 이당류를 정제하는 단계를 더 포함할 수 있다. 이때 정제에 관한 사항은 다당류의 효소 반응 이후 반응혼합물로부터 특정 반응생성물을 정제하는 통상적인 방법을 참조할 수 있다.The disaccharide production method of the present invention may further include the step of purifying the disaccharide produced after contacting it with xylan. At this time, for purification matters, refer to the usual method of purifying a specific reaction product from the reaction mixture after the enzymatic reaction of polysaccharide.
상기와 같은 본 발명 균주의 특징을 바탕으로 본 발명은 또한 본 발명 균주의 배양물 또는 상기 배양물의 정제물을 포함하는 이당류 제조용 조성물을 제공한다.Based on the above characteristics of the strain of the present invention, the present invention also provides a composition for producing disaccharides comprising a culture of the strain of the present invention or a purified product of the culture.
본 발명의 이당류 제조용 조성물에서 배양물 및 정제물에 관한 사항은 위에서 설명한 내용을 참조할 수 있다.Details regarding culture and purification in the composition for producing disaccharides of the present invention can be referred to the information described above.
본 발명의 이당류 제조용 조성물은 상기 배양물 또는 정제물 이외에 다른 성분을 더 포함할 수 있다. 예를 들어, 상기 배양물 또는 정제물에 의한 자일란의 분해 활성을 실질적으로 저해하지 않는 성분으로, 당분해 효소의 안정적인 작용을 위한 완충제, 희석제, 부형제 등을 더 포함할 수 있다.The composition for producing disaccharides of the present invention may further include other ingredients in addition to the culture or purification. For example, ingredients that do not substantially inhibit the decomposition activity of xylan by the culture or purification may further include buffers, diluents, excipients, etc. for stable action of the glycolytic enzyme.
본 발명의 이당류 제조용 조성물은 상기 배양물 또는 정제물을 예를 들어 조성물 총 중량을 기준으로 0.001 내지 100%로 포함할 수 있다.The composition for producing a disaccharide of the present invention may include, for example, 0.001 to 100% of the culture or purified product based on the total weight of the composition.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail through examples. Since these examples are merely for illustrating the present invention, the scope of the present invention is not to be construed as limited by these examples.
[실시예][Example]
1. 방법1. Method
1-1. 균주 분리1-1. Strain isolation
인천시 서구 일대에서 채집된 장미꽃 1송이를 80% 에탄올 200㎖에 담가 10초간 살균하고 멸균수 500㎖에 4회 세척하였다. 물기가 제거된 시료에 멸균수 50㎖를 가하여 막자사발에서 완전히 으깬 후 상등액 200㎕를 MRS 고체배지에 도말하고 25℃에서 2일간 배양하여 생성된 콜로니를 얻었다. 총 8개의 콜로니를 얻었으며, 형태적으로 8개의 콜로니 모두 진균(효모로 추정)으로 구분되었다.One rose flower collected from the Seo-gu area of Incheon was sterilized by soaking it in 200 ml of 80% ethanol for 10 seconds and washed four times in 500 ml of sterilized water. 50 ㎖ of sterilized water was added to the sample from which water was removed, and the sample was thoroughly crushed in a mortar. 200 ㎕ of the supernatant was spread on MRS solid medium and cultured at 25°C for 2 days to obtain the resulting colonies. A total of 8 colonies were obtained, and all 8 colonies were morphologically classified as fungi (presumed to be yeast).
8개의 콜로니를 0.2% AZCL(Azurine-crosslinked)-자일란(xylan)이 포함된 PDA 고체배지에 옮긴 후 25℃에서 5일간 배양하여 푸른색을 띄는 것으로부터 분해 활성을 확인하여 활성이 강한 1개의 균주를 최종 선발하였다.Eight colonies were transferred to PDA solid medium containing 0.2% AZCL (Azurine-crosslinked)-xylan and cultured at 25°C for 5 days. Decomposition activity was confirmed from the blue color, resulting in one highly active strain. was finally selected.
최종 선발된 균주를 RN2로 명명하였다.The final selected strain was named RN2.
1-2. 균주 동정1-2. Strain identification
RN2를 동정하기 위해, ITS1F(5'-CTTGGTCATTTAGAGGAAGTAA-3') 및 ITS4(5'-TCCTCCGCTTATTGATATGC-3') 프라이머를 사용하여 ITS 영역의 염기서열을 분석하고, NL1(5'-GCATATCAATAAGCGGAGGAAAAG-3') 및 NL4(5'-GGTCCGTGTTTCAAGACGG-3') 프라이머를 사용하여 D1D2 영역의 염기서열을 분석하였다.To identify RN2, the ITS region was sequenced using primers ITS1F (5'-CTTGGTCATTTAGAGGAAGTAA-3') and ITS4 (5'-TCCTCCGCTTATTGATATGC-3') and NL1 (5'-GCATATCAATAAGCGGAGGAAAAG-3'). And the nucleotide sequence of the D1D2 region was analyzed using primers NL4 (5'-GGTCCGTGTTTCAAGACGG-3').
ITS 영역 및 D1D2 영역의 염기서열을 바탕으로 NCBI(National Center for Biotechnology Information)의 BlastN 프로그램을 사용하여 GenBank 데이터베이스 정보로부터 염기서열의 상동성 분석을 수행하였다. 계통수 분석을 위해서, 상동성을 보이는 균주들의 ITS-D1D2 서열을 확보하고 Mega X 프로그램으로 NJ(Neighbor-Joining) 계통수를 제작하여 계통발생적 연관성을 분석하였다.Based on the nucleotide sequences of the ITS region and the D1D2 region, homology analysis of the nucleotide sequence was performed from the GenBank database information using the BlastN program of the National Center for Biotechnology Information (NCBI). For phylogenetic tree analysis, the ITS-D1D2 sequences of strains showing homology were obtained, and a NJ (Neighbor-Joining) phylogenetic tree was created using the Mega X program to analyze phylogenetic relationships.
1-3. 형태적 및 생리적 특성 분석1-3. Analysis of morphological and physiological characteristics
RN2를 PDA 배지에서 배양하여 배지 상에서 생장하면서 변하는 콜로니의 형태를 관찰하였고, 배양 7일째에 Axio Imager Z2 현미경(Zeiss)을 사용하여 균사를 관찰하였다.RN2 was cultured in PDA medium to observe the changing morphology of colonies as they grew on the medium, and on the 7th day of culture, hyphae were observed using an Axio Imager Z2 microscope (Zeiss).
생리학적 특성은 API 20NE, API 20E, API ZYM 키트(Biomerieux, France)를 사용하여 제시된 방법에 따라 조사하였다. 균체 시료는 RN2를 PDA 배지에서 2일간 배양하여 수득하였다.Physiological characteristics were investigated using API 20NE, API 20E, and API ZYM kits (Biomerieux, France) according to the presented method. The bacterial sample was obtained by culturing RN2 in PDA medium for 2 days.
1-4. 다당체 분해 활성 분석1-4. Polysaccharide degradation activity analysis
RN2의 다당체 분해 활성을 알아보기 위해, RN2를 0.2% AZCL-자일란, -아밀로오스(amylose), -아라비노자일란(arabinoxylan), -셀룰로오스(cellulose), -풀루란(pullulan)이 각각 함유된 PDA 배지에 도말접종한 후 25℃에서 48시간 배양하여 콜로니 주변으로 AZCL 기질이 분해되어 푸른색을 띄는 것을 관찰하였다.To examine the polysaccharide decomposition activity of RN2, RN2 was cultured on PDA medium containing 0.2% AZCL-xylan, -amylose, -arabinoxylan, -cellulose, and -pullulan, respectively. After inoculation, it was cultured at 25°C for 48 hours, and it was observed that the AZCL matrix around the colonies was decomposed and turned blue.
RN2를 200㎖의 PDB 액체배지에 접종하고 30℃에서 10일간 배양하면서 3일 간격으로 배양액을 5㎖씩 샘플링하고, 15,000rpm에서 30분간 원심분리하여 균체를 제거한 상등액 만을 취하였다. 준비된 상등액을 0.22㎛ 시린지 필터로 필터링하여 효소액으로 사용하였으며, 자일라나아제(xylanase) 활성을 DNS(dinitrosalicylic acid) 방법[Miller GL. 1959. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal. Chem. 31: 426-428.]으로 확인하였고, 흡광도 540㎚에서 효소 반응으로 유리되는 환원당의 양을 측정하였다.RN2 was inoculated into 200 ml of PDB liquid medium and cultured at 30°C for 10 days, sampling 5 ml of the culture medium every 3 days, and centrifuged at 15,000 rpm for 30 minutes to remove only the supernatant. The prepared supernatant was filtered through a 0.22㎛ syringe filter and used as an enzyme solution, and xylanase activity was measured using the DNS (dinitrosalicylic acid) method [Miller GL. 1959. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal. Chem. 31: 426-428.], and the amount of reducing sugar liberated by the enzyme reaction was measured at an absorbance of 540 nm.
1-5. TLC 분석1-5. TLC analysis
RN2가 자일란을 분해하여 생산하는 가수분해산물을 분석하기 위해, 균의 생장 시기별 효소활성도 측정 결과 가장 높은 활성을 보이는 3일째의 시료를 Amicon 초원심분리 필터(ultracentrifugal filter)(10KDa 컷-오프, Millipore, 미국)로 농축하여 10배 농축된 조효소액을 준비하였다.To analyze the hydrolysis products produced by RN2 by decomposing xylan, samples from the 3rd day, which showed the highest activity as a result of measuring enzyme activity by bacterial growth period, were filtered through an Amicon ultracentrifugal filter (10KDa cut-off, Millipore, USA) was used to prepare a 10-fold concentrated crude enzyme solution.
자일란 분해산물을 분석하기 위해, 조효소액 100㎕를 0.4% 자일란이 함유된 1X 인산 완충 염수(PBS)에 첨가하여 37℃에서 24시간 반응시켰다. 효소반응 동안 12시간 간격으로 효소반응액을 샘플링하여 실리카겔 60 플레이트(Merck)에 20㎕씩 가하였다. 이때 자일로바이오스(xylobiose)와 자일로테트라오스(xylotetraose), 자일로헥사오스(xylohexaose)(Megazyme, 아일랜드)를 표준물로 사용하였다. 전개용매로 n-부탄올 : 아세트산 : 증류수(2:1:2) 용액을 사용하였으며, 발색시약은 에탄올 : 황산(9:1) 용액을 사용하였다. 전개 후 발색시약을 골고루 뿌리고 120℃에서 가열하여 확인하였다.To analyze xylan degradation products, 100 ㎕ of crude enzyme solution was added to 1X phosphate buffered saline (PBS) containing 0.4% xylan and reacted at 37°C for 24 hours. During the enzyme reaction, the enzyme reaction solution was sampled at 12-hour intervals and 20 μl was added to a silica gel 60 plate (Merck). At this time, xylobiose, xylotetraose, and xylohexaose (Megazyme, Ireland) were used as standards. A solution of n-butanol: acetic acid: distilled water (2:1:2) was used as a developing solvent, and a solution of ethanol: sulfuric acid (9:1) was used as a color developing reagent. After development, the color development reagent was evenly sprinkled and confirmed by heating at 120°C.
2. 결과2. Results
2-1. RN2의 분리 및 동정2-1. Isolation and identification of RN2
RN2는 장미꽃 시료로부터 자일란 분해 효소 활성을 보이는 균주로서 최종 선발되었다.RN2 was finally selected as a strain showing xylan decomposition enzyme activity from rose flower samples.
RN2는 PDA 배지에서 배양하였을 때, 콜로니의 중앙부위가 검은색을 띄지만 전체적으로는 연한 분홍색을 띄었다. 가장자리는 균사 모양으로 자라나오며, 일반적인 곰팡이 배양속도에 비해 느린 것을 확인할 수 있었다. 현미경 관찰에서는 타원형 모양(일반적인 효모(yeast)의 형태와 비슷함)으로 자라는 것을 확인할 수 있었다(도 2).When RN2 was cultured in PDA medium, the central part of the colony was black, but the overall color was light pink. The edges grew in the shape of hyphae, and it was confirmed that the speed of mold cultivation was slower than that of general mold cultivation. Microscopic observation confirmed that it grew in an oval shape (similar to the shape of a typical yeast) (Figure 2).
RN2의 ITS-D1D2 서열을 분석하여 크립토클라인(Cryptocline) 속의 한 종으로 분류하였다. RN2는 NCBI Blast 상동성 분석 결과, 크립토클라인 아르크토스타필리(Cryptocline arctostaphyli)와 99.83%의 가장 높은 상동성을 보였다(표 1). 또한 크립토클라인 속 균주를 포함하여 프링쉐이미아(Pringsheimia) 속 균주, 아우레오바시디움(Aureobasidium) 속 균주, 슈도사이도위아(Pseudosydowia) 속 균주, 사코테시움(Saccothecium) 속 균주 등의 ITS-D1D2 서열을 토대로 NJ(Neighbor-Joining) 계통수를 제작한 결과, 크립토클라인 아르크토스타필리와 같은 계통 분기를 형성하여 같은 종으로 판단되었다(도 1). ITS-D1D2 서열 상동성 검색 결과와 NJ 계통수 제작 결과를 토대로 RN2를 크립토클라인 아르크토스타필리로 동정하였다. 최종적으로 본 발명에서 발굴된 균주 RN2를 크립토클라인 아르크토스타필리 RN2로 명명하였다.By analyzing the ITS-D1D2 sequence of RN2, it was classified as a species in the genus Cryptocline . As a result of NCBI Blast homology analysis, RN2 showed the highest homology of 99.83% with Cryptocline arctostaphyli (Table 1). In addition , ITS- As a result of constructing a Neighbor-Joining (NJ) phylogenetic tree based on the D1D2 sequence, it formed the same phylogenetic branch as Cryptocline Arctostaphylli and was judged to be the same species (Figure 1). Based on the ITS-D1D2 sequence homology search results and the NJ phylogenetic tree construction results, RN2 was identified as Cryptocline Arctostaphylli. Finally, the strain RN2 discovered in the present invention was named Cryptocline Arctostaphylli RN2.
크립토클라인 아르크토스타필리 RN2는 API ZYM 키트를 이용하여 19종의 효소활성을 측정한 결과, 알칼라인 포스파타아제(alkaline phosphatase), 에스터라제(esterase)(C4), 에스터라제 리파아제(esterase lipase)(C8), 리파아제(lipase)(C14), 루신 아릴아미다아제(leucine arylamidase), 발린 아릴아미다아제(valine arylamidase), 시스틴 아릴아미다아제(cystine arylamidase), 트립신(trypsin), 알파-카이모트립신(α-chymotrypsin), 산성 포스파타아제(acid phosphatase), 나프톨-AS-BI-포스포하이드롤라아제(Naphthol-AS-BI-phosphohydrolase), 알파-갈락토시다아제(α-galactosidase), 베타-갈락토시다아제(β-galactosidase), 베타-글루쿠로니다아제(β-glucuronidase), 알파-글루코시다아제(α-glucosidase), 베타-글루코시다아제(β-glucosidase), N-아세틸-베타-글루코사마니다아제(N-acetyl-β-glucosaminidase)의 활성에는 양성이었고 그 외 두 가지의 효소 활성은 음성이었다. API 20E 키트를 이용한 효소활성과 발효반응을 측정한 결과, 베타-갈락토시다아제, 우레아제(urease), 트립토판 디아미나아제(tryptophane deaminase) 효소 활성은 양성이었고 그 외 효소반응은 음성이었다. 그리고 당류에 대한 발효 테스트 결과, D-글루코오스(D-glucose), D-수크로오스(D-sucrose), D-멜리바이오스(D-melibiose), 아미그달린(amygdalin) 등에 양성이었고 나머지 5종의 당류에서는 발효가 관찰되지 않았다. API 20NE 키트 테스트에서 우레아제, 에스쿨린(esculin) 분해, 베타-갈락토시다아제 효소활성과 글루코오스 발효반응이 양성이었고, 탄소원으로서 D-글루코오스, L-아라비노오스(L-arabinose), D-만노오스(D-mannose), D-만니톨(D-mannitol), D-말토오스(D-maltose), 글루콘산 칼륨에는 양성 반응을 보였다. 그 외 효소 및 탄소원 사용에 관한 반응은 음성이었다.Cryptocline Arctostaphylli RN2 was measured for 19 enzyme activities using the API ZYM kit, and the results showed alkaline phosphatase, esterase (C4), and esterase lipase. ) (C8), lipase (C14), leucine arylamidase, valine arylamidase, cystine arylamidase, trypsin, alpha- α-chymotrypsin, acid phosphatase, Naphthol-AS-BI-phosphohydrolase, α-galactosidase, Beta-galactosidase, beta-glucuronidase, alpha-glucosidase, beta-glucosidase, N-acetyl -The activity of beta-glucosamanidase (N-acetyl-β-glucosaminidase) was positive, and the other two enzyme activities were negative. As a result of measuring enzyme activity and fermentation reaction using the API 20E kit, beta-galactosidase, urease, and tryptophane deaminase enzyme activities were positive, and other enzyme reactions were negative. And the fermentation test results for sugars were positive for D-glucose, D-sucrose, D-melibiose, and amygdalin, and the remaining five types of sugars were fermented. was not observed. In the API 20NE kit test, urease, esculin degradation, beta-galactosidase enzyme activity, and glucose fermentation reaction were positive, and D-glucose, L-arabinose, and D-mannose as carbon sources. (D-mannose), D-mannitol (D-mannitol), D-maltose (D-maltose), and potassium gluconate showed positive reactions. Other reactions related to the use of enzymes and carbon sources were negative.
기호: +, 양성; +-, 약한 양성; -, 음성.Symbol: +, positive; +-, weakly positive; -, voice.
(Vogesproskauer)acetoin production
(Vogesproskauer)
기호: +, 양성; +-, 약한 양성; -, 음성.Symbol: +, positive; +-, weakly positive; -, voice.
기호: +, 양성; +-, 약한 양성; -, 음성.Symbol: +, positive; +-, weakly positive; -, voice.
2-2. 다당체 분해 활성2-2. Polysaccharide decomposition activity
크립토클라인 아르크토스타필리 RN2는 균체 주변으로 비용해성 AZCL-아밀로오스, AZCL-아라비노자일란, AZCL-자일란을 분해하여 배지에 푸른색을 나타낸 것으로부터 분해 효소를 세포외부로 분비하는 것을 알 수 있었다. 3종의 효소 활성 중에서는 자일란 분해 활성이 가장 강하게 관찰되었고 다음으로 아라비노자일란 분해 활성이 높았으며, 다음으로 아밀로오스 분해 활성이 뒤따랐다(도 3).Cryptocline Arctostaphili RN2 decomposes insoluble AZCL-amylose, AZCL-arabinoxylan, and AZCL-xylan around the cell, and appears blue in the medium, showing that it secretes decomposing enzymes to the outside of the cell. Among the three types of enzyme activities, xylan decomposition activity was observed to be the strongest, followed by arabinoxylan decomposition activity, followed by amylose decomposition activity (Figure 3).
AZCL-자일로글루칸, -셀룰로오스, -풀루란에 대한 분해 활성은 관찰되지 않은 것으로부터 자일로글루카나아제(xyloglucanase), 셀룰라아제(cellulase), 풀루라나아제(pullulanase) 효소는 생산하지 않는 것으로 추측된다.Since decomposition activity for AZCL-xyloglucan, -cellulose, and -pullulan was not observed, it is assumed that xyloglucanase, cellulase, and pullulanase enzymes are not produced. .
PDB 배지에서 크립토클라인 아르크토스타필리 RN2의 액체배양에 따른 자일라나아제 활성을 측정하였을 때, 3일째 시료에서 가장 높은 효소활성이 보이다가 5일째부터 급격히 감소하였다(도 4).When measuring xylanase activity according to liquid culture of Cryptocline Arctostaphylli RN2 in PDB medium, the highest enzyme activity was seen in the sample on the 3rd day, but rapidly decreased from the 5th day (Figure 4).
크립토클라인 아르크토스타필리 RN2의 액체배양 3일째 시료로부터 준비된 조효소액을 이용하여 자일란을 기질로한 효소반응산물을 TLC로 분석하였을 때, 크립토클라인 아르크토스타필리 RN2가 분비하는 자일라나아제는 비치우드(beechwood) 자일란을 분해하여 이량체(dimer)(DP2)를 주요 분해산물로 생산하는 것을 알 수 있었다(도 5). 최종 분해산물인 이량체를 포함하여 6량체(DP6)보다 긴 구조의 올리고당이 생산되는 것을 확인하였으며, 이러한 TLC 패턴은 일반적인 엔도-유형(endo-type) 자일라나아제의 가수분해 특성과 일치한다. 따라서 크립토클라인 아르크토스타필리 RN2의 효소를 이용한다면, 자일란으로부터 이량체를 주요 산물로하는 자일로올리고당(xylooligosaccharide)의 생산이 가능할 것으로 판단된다.When the enzyme reaction product using xylan as a substrate was analyzed by TLC using the crude enzyme solution prepared from the sample of the 3rd day of liquid culture of Cryptocline Arctostaphylli RN2, the xylanase secreted by Cryptocline Arctostaphylli RN2 was not present. It was found that beechwood xylan was decomposed to produce dimer (DP2) as the main decomposition product (FIG. 5). It was confirmed that oligosaccharides with a structure longer than the hexamer (DP6) were produced, including the dimer, which is the final decomposition product, and this TLC pattern is consistent with the hydrolysis characteristics of a general endo-type xylanase. Therefore, it is believed that by using the enzyme of the cryptocline Arctostaphylli RN2, it is possible to produce xylooligosaccharide, which uses dimers as the main product from xylan.
<110> National Institute of Biological Resources <120> Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity <130> ALP21012 <160> 2 <170> KoPatentIn 3.0 <210> 1 <211> 569 <212> DNA <213> Unknown <220> <223> Cryptocline arctostaphyli RN2 <400> 1 cggaaggatc attaaagaga aaggggctaa acaccccgac ctccaaccct ctgttgttaa 60 aactactttg ttgctttggc gggaccgttc ggtctccgag ccgcccaggc accttcacgg 120 gtgtccaggc gagtgcccgc cagagttaaa ccaaactctt gttatttaaa ccggtcgtct 180 gagtacaaat ttttgaatta aatcaaaact ttcaacaacg gatctcttgg ttctcgcatc 240 gatgaagaac gcagcgaaat gcgataagta atgtgaattg cagaattcag tgaatcatcg 300 aatctttgaa cgcacattgc gccccttggt attccgaggg gcatgcctgt tcgagcgtca 360 ttacaccact caagcatagc ttggtattgg gcaatcgccc ccgccagtcg gggacgcgcc 420 tcaaacacct cggcggagcc tcaccggctt tgggcgtagt agaatttcta ataacgtcct 480 ttaacggaga tggttccttt gccgacagaa gcctttaaat ttttctaggt tgacctcgga 540 tcaggtaggg atacccgctg aacttaagc 569 <210> 2 <211> 591 <212> DNA <213> Unknown <220> <223> Cryptocline arctostaphyli RN2 <400> 2 aggaaaagaa accaacaggg attgccctag taacggcgag tgaagcggca acagctcaaa 60 tttgaaagct agccttcggg ttcgcattgt aatttgtaga ggatgctttg gggcagccgc 120 ctgtctaagt tccttggaac aggacgtcat agagggtgag aatcccgtat gtgacaggac 180 atggcaccct atgtaaagct ccttcgacga gtcgagttgt ttgggaatgc agctctaaat 240 gggaggtaaa tttcttctaa agctaaatac cggcgagaga ccgatagcgc acaagtagag 300 tgatcgaaag atgaaaagca ctttggaaag agagttaaaa agcacgtgaa attgttgaaa 360 gggaagcgct tgcaatcaga cttgtcttta actgttcggc cggtcttctg accggtttac 420 tcagtaatcg acaggccagc atcagtttcg gcggtcggat aaaggccctg ggaatgtggc 480 tctgccttcg ggtagagtgt tatagcccag ggtgtaatac ggccagccgg gactgaggtc 540 cgcgattcgt ctaggatgct ggcgtaatgg ttgtaagcga cccgtcttga a 591 <110> National Institute of Biological Resources <120> Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity <130> ALP21012 <160> 2 <170> KoPatentIn 3.0 <210> 1 <211> 569 <212> DNA <213> Unknown <220> <223> Cryptocline arctostaphyli RN2 <400> 1 cggaaggatc attaaagaga aaggggctaa acaccccgac ctccaaccct ctgttgttaa 60 aactactttg ttgctttggc gggaccgttc ggtctccgag ccgcccaggc accttcacgg 120 gtgtccaggc gagtgcccgc cagagttaaa ccaaactctt gttatttaaa ccggtcgtct 180 gagtacaaat ttttgaatta aatcaaaact ttcaacaacg gatctcttgg ttctcgcatc 240 gatgaagaac gcagcgaaat gcgataagta atgtgaattg cagaattcag tgaatcatcg 300 aatctttgaa cgcacattgc gccccttggt attccgaggg gcatgcctgt tcgagcgtca 360 ttacaccact caagcatagc ttggtattgg gcaatcgccc ccgccagtcg gggacgcgcc 420 tcaaacacct cggcggagcc tcaccggctt tgggcgtagt agaatttcta ataacgtcct 480 ttaacggaga tggttccttt gccgacagaa gcctttaaat ttttctaggt tgacctcgga 540 tcaggtaggg atacccgctg aacttaagc 569 <210> 2 <211> 591 <212> DNA <213> Unknown <220> <223> Cryptocline arctostaphyli RN2 <400> 2 aggaaaaagaa accaacaggg attgccctag taacggcgag tgaagcggca acagctcaaa 60 tttgaaagct agccttcggg ttcgcattgt aatttgtaga ggatgctttg gggcagccgc 120 ctgtctaagt tccttggaac aggacgtcat agagggtgag aatcccgtat gtgacaggac 180 atggcaccct atgtaaagct ccttcgacga gtcgagttgt ttgggaatgc agctctaaat 240 gggaggtaaa tttcttctaa agctaaatac cggcgagaga ccgatagcgc acaagtagag 300 tgatcgaaag atgaaaagca ctttggaaag agagttaaaa agcacgtgaa attgttgaaa 360 gggaagcgct tgcaatcaga cttgtcttta actgttcggc cggtcttctg accggtttac 420 tcagtaatcg acaggccagc atcagtttcg gcggtcggat aaaggccctg ggaatgtggc 480 tctgccttcg ggtagagtgt tatagcccag ggtgtaatac ggccagccgg gactgaggtc 540 cgcgattcgt ctaggatgct ggcgtaatgg ttgtaagcga cccgtcttga a 591
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210087871A KR102612094B1 (en) | 2021-07-05 | 2021-07-05 | Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210087871A KR102612094B1 (en) | 2021-07-05 | 2021-07-05 | Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230007077A KR20230007077A (en) | 2023-01-12 |
KR102612094B1 true KR102612094B1 (en) | 2023-12-12 |
Family
ID=84923614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210087871A KR102612094B1 (en) | 2021-07-05 | 2021-07-05 | Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102612094B1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101098545B1 (en) * | 2009-10-19 | 2011-12-26 | 건국대학교 산학협력단 | a Xylanase producing microorganism and an optimizing method of xylanase production |
KR101746398B1 (en) * | 2015-10-12 | 2017-06-14 | 대한민국 | Streptomyces atrovirens WJ2, a new microbe having great activity degrading xylan |
-
2021
- 2021-07-05 KR KR1020210087871A patent/KR102612094B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20230007077A (en) | 2023-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sanjivkumar et al. | Biosynthesis, purification and characterization of β-1, 4-xylanase from a novel mangrove associated actinobacterium Streptomyces olivaceus (MSU3) and its applications | |
KR20110119386A (en) | Gene coding for cellulase from bacillus velezensis a-68 and production method of cellulase by transformed escherichia coli a-68 thereof | |
CN105431534A (en) | beta-1,3-glucanase, polynucleotide, recombinant vector, transformant, production method for beta-1,3-glucanase, enzyme preparation, and production method for paramylon having reduced molecular weight | |
JP5718899B2 (en) | Changes in enzyme balance depending on fermentation conditions | |
Jasim | Isolation and molecular characterisation xylanase produced by sporolactobacilli | |
Kovacs et al. | Production of chitinolytic enzymes with Trichoderma longibrachiatum IMI 92027 in solid substrate fermentation | |
KR102612094B1 (en) | Novel strain Cryptocline arctostaphyli RN2 having xylan degrading activity | |
TW201420760A (en) | Bacillus subtilis and application thereof | |
KR102612093B1 (en) | Novel strain Aureobasidium pullulans RG4 having xylan degrading activity | |
Neagu et al. | Trichoderma reesei cellulase produced by submerged versus solid state fermentations | |
WO2011049205A1 (en) | Method for production of lactic acid by non-sterile fermentation | |
KR101746398B1 (en) | Streptomyces atrovirens WJ2, a new microbe having great activity degrading xylan | |
US6569646B2 (en) | Process for the production of an enzyme preparation containing xylanase and carboxymethyl cellulase from termitomyces clypeatus having accession no 11CB-411 | |
Rahmani et al. | Endo-xylanase enzyme from marine actinomycetes and its potential for xylooligosaccharide production | |
KR101098545B1 (en) | a Xylanase producing microorganism and an optimizing method of xylanase production | |
KR100523528B1 (en) | Novel Cellulomonas sp. GM13 strain producing chitinase | |
KR100625299B1 (en) | Microorganism for decomposing Laminaria japonica and Undaria pinnatifida and a method for decomposing Laminaria japonica and Undaria pinnatifida using the same | |
KR100862397B1 (en) | A composition for discompositing xylane by use of Bacillus sp producing xylanolytic enzyme | |
KR101518200B1 (en) | Xylanase produced from Streptomyces sp. CS624 and application of agricultural by-product decomposition | |
KR102038287B1 (en) | A novel Cellulophaga sp., producing new saccharogenic enzyme and use thereof | |
KR101453389B1 (en) | Novel Microorganism Having Degrading Acitivity of Cellulose, Protein and Lipid | |
CN113717876B (en) | Broussonetia papyrifera leaf endophytic bacterium with lignocellulose degradation function | |
Ouahiba et al. | Optimization of endoglucanase production from Sarocladium kiliense strain BbV1 under solid state fermentation, using response surface methodology | |
El-Gawad et al. | Optimization of cellulases production under fermintation conditions by halophilic Aspergillus niger | |
KR100664582B1 (en) | Chitinase-producing trichoderma viride ????-?41 strain, chitinases purified therefrom and a method for producing ?-acetylglucosamine using the chitinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |